Luminex Corp. (LMNX) Tops Q1 EPS by 21c, Raises FY Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Luminex Corporation Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance
May 1, 2017 4:05 PM EDTAUSTIN, Texas, May 1, 2017 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced financial results for the first quarter of 2017. Financial and operating highlights for the quarter include the following:
Consolidated revenue of $77.8 million, an increase of 23% compared to the first quarter 2016. Total Verigene related revenue of $10.5 million; growth of 59% over its first quarter 2016. Corporate gross margin increased to 68% from 61% in the fourth quarter, 2016 primarily due to overall product mix and improving gross margins on our automated sample to answer molecular products. GAAP net income of $9.2... More